Rebuttal: Time to call a halt to emotions in the assessment of thioacetazone

Elliott, 1995, The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia, Trans Roy Soc Trop Med Hyg, 89, 78, 10.1016/0035-9203(95)90668-1 Elliott, 1996, Thiacetazone: time to call a halt?, 77, 27 Raviglione, 1988, Fatal toxic epidermal necrolysis during prophylaxis with pyrimethamine and sulfadoxine in a human immunodeficiency virus-infected person, Arch Intern Med, 148, 2683, 10.1001/archinte.1988.00380120121024 Gordin, 1984, Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome, Ann Intern Med, 100, 495, 10.7326/0003-4819-100-4-495 Mitsuyasu, 1983, Cutaneous reactions to trimethoprimsulfamethoxazole in patients with AIDS and Kaposi sarcoma, N Engl J Med, 308, 1535, 10.1056/NEJM198306233082512 Jaffe, 1983, Complications of cotrimoxazole in treatment of AIDS-associated Pneumocystis carinii pneumonia in homosexual men, Lancet, 2, 1109, 10.1016/S0140-6736(83)90627-X Coopman, 1991, Cutaneous drug reactions in human immunodeficiency virus infection, Arch Dermatol, 127, 714, 10.1001/archderm.1991.01680040122017 Nunn, 1991, Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis, Lancet, 337, 627, 10.1016/0140-6736(91)92447-A Mitchison, 1985, The action of antituberculosis drugs in short-course chemotherapy, Tubercle, 66, 219, 10.1016/0041-3879(85)90040-6 East African/British Medical Research Council, 1980, Controlled clinical trial of four short-course regimens of chemotherapy for two durations in the treatment of pulmonary tuberculosis, 59 Tanzania/British Medical Research Council Study, 1985, Controlled clinical trial of two 6-month regimens of chemotherapy in the treatment of pulmonary tuberculosis, Am Rev Respir Dis, 131, 727 Union International Contre la Tuberculose et les Maladies Respiratoires, 1992 International Union Against Tuberculosis and Lung Disease, 1995, The National Tuberculosis/Leprosy Programme in Tanzania, Progress Report No. 34. International Union Against Tuberculosis and Lung Disease, 1994, Report No. 20 Murray, 1991, Cost effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries, Lancet, 338, 1305, 10.1016/0140-6736(91)92600-7 Enarson, 1994 World Health Organization, 1991, Guidelines for tuberculosis treatment in adults and children in national tuberculosis programmes, World Health Organization Document WHO/TUB/91.161. Geneva Nunn, 1994, Tuberculosis — from neglect to control, Trans Roy Soc Trop Med Hyg, 88, 129, 10.1016/0035-9203(94)90262-3 Nunn, 1994, Surveillance of drug resistance to antituberculosis drugs in developing countries, Tubercle Lung Dis, 75, 163, 10.1016/0962-8479(94)90001-9 Kelly, 1994, Cutaneous reactions to thioacetazone in Zambia — implications for tuberculosis treatment strategies, Trans Roy Soc Trop Med Hyg, 88, 113, 10.1016/0035-9203(94)90529-0 Ipuge, 1995, Adverse cutaneous reactions to thiacetazone for tuberculosis treatment in Tanzania, Lancet, 346, 657, 10.1016/S0140-6736(95)92278-4